Article info

Original research
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy

Authors

  • Jie Dai Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xue Bai Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xuan Gao State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, ChinaGenePlus- Shenzhen Clinical Laboratory, Shenzhen, China PubMed articlesGoogle scholar articles
  • Lirui Tang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Yu Chen Department of Medical Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China PubMed articlesGoogle scholar articles
  • Linzi Sun Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xiaoting Wei Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Caili Li Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Zhonghui Qi Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Yan Kong Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Chuanliang Cui Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Zhihong Chi Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xinan Sheng Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Zelong Xu Geneplus-Beijing, Beijing, China PubMed articlesGoogle scholar articles
  • Bin Lian Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Siming Li Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xieqiao Yan Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Bixia Tang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Li Zhou Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xuan Wang Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Xuefeng Xia Geneplus-Beijing, Beijing, China PubMed articlesGoogle scholar articles
  • Jun Guo Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Lili Mao Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  • Lu Si Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lu Si; silu15_silu{at}126.com; Dr Lili Mao; yunzhongmanbu7848{at}163.com
View Full Text

Citation

Dai J, Bai X, Gao X, et al
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy

Publication history

  • Accepted December 7, 2022
  • First published January 2, 2023.
Online issue publication 
December 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.